Bio Green Med Solution Statistics
Total Valuation
BGMS has a market cap or net worth of $5.30 million. The enterprise value is $1.80 million.
Important Dates
The next estimated earnings date is Thursday, May 14, 2026, before market open.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BGMS has 5.52 million shares outstanding. The number of shares has increased by 9,692.40% in one year.
| Current Share Class | 5.52M |
| Shares Outstanding | 5.52M |
| Shares Change (YoY) | +9,692.40% |
| Shares Change (QoQ) | +140.88% |
| Owned by Insiders (%) | 32.24% |
| Owned by Institutions (%) | 1.46% |
| Float | 3.46M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.09 |
| Forward PS | n/a |
| PB Ratio | 0.76 |
| P/TBV Ratio | 1.01 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.40 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.70, with a Debt / Equity ratio of 0.00.
| Current Ratio | 4.70 |
| Quick Ratio | 3.58 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -128.45% and return on invested capital (ROIC) is -225.56%.
| Return on Equity (ROE) | -128.45% |
| Return on Assets (ROA) | -85.79% |
| Return on Invested Capital (ROIC) | -225.56% |
| Return on Capital Employed (ROCE) | -122.97% |
| Weighted Average Cost of Capital (WACC) | 1.31% |
| Revenue Per Employee | $62,250 |
| Profits Per Employee | -$1.17M |
| Employee Count | 12 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BGMS has paid $7,000 in taxes.
| Income Tax | 7,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.56% in the last 52 weeks. The beta is -0.53, so BGMS's price volatility has been lower than the market average.
| Beta (5Y) | -0.53 |
| 52-Week Price Change | -98.56% |
| 50-Day Moving Average | 1.00 |
| 200-Day Moving Average | 3.48 |
| Relative Strength Index (RSI) | 42.71 |
| Average Volume (20 Days) | 160,680 |
Short Selling Information
The latest short interest is 59,393, so 1.08% of the outstanding shares have been sold short.
| Short Interest | 59,393 |
| Short Previous Month | 23,283 |
| Short % of Shares Out | 1.08% |
| Short % of Float | 1.72% |
| Short Ratio (days to cover) | 0.41 |
Income Statement
In the last 12 months, BGMS had revenue of $747,000 and -$14.09 million in losses. Loss per share was -$6.45.
| Revenue | 747,000 |
| Gross Profit | -673,000 |
| Operating Income | -8.43M |
| Pretax Income | -2.99M |
| Net Income | -14.09M |
| EBITDA | -8.42M |
| EBIT | -8.43M |
| Loss Per Share | -$6.45 |
Full Income StatementBalance Sheet
The company has $3.51 million in cash and $2,000 in debt, giving a net cash position of $3.50 million or $0.63 per share.
| Cash & Cash Equivalents | 3.51M |
| Total Debt | 2,000 |
| Net Cash | 3.50M |
| Net Cash Per Share | $0.63 |
| Equity (Book Value) | 6.84M |
| Book Value Per Share | 1.27 |
| Working Capital | 4.92M |
Full Balance SheetCash Flow
| Operating Cash Flow | -4.77M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 5,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -4.77M |
| FCF Per Share | -$0.86 |
Full Cash Flow StatementMargins
| Gross Margin | -90.09% |
| Operating Margin | -1,128.11% |
| Pretax Margin | -400.40% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |